presumptive active pulmonary tuberculosis (TB) was detected in 44 health care workers (HCWs) at a university hospital in Lima, Peru. To further assess the magnitude of the outbreak and determine risk factors for occupational Mycobacterium tuberculosis transmission, we identified HCWs in whom active pulmonary TB was diagnosed from January 1994 through January 1998, calculated rates by year and hospital work area, and conducted a tuberculin skin test (TST) survey. Thirty-six HCWs had confirmed active pulmonary TB. The rate of TB was significantly higher among the 171 HCWs employed in the laboratory than among HCWs employed in all other areas. In multivariate analysis, the only independent risk factor for HCW M. tuberculosis infection in HWCs employed in the laboratory was the use of common staff areas. Very high rates of active pulmonary TB were detected among HCWs at this hospital, and occupational acquisition in the laboratory was associated with HCW-to-HCW transmission.
in 1998, 16 million people worldwide were infected with Mycobacterium tuberculosis, 7 million developed active disease, and almost 2 million died of TB. Approximately 250,000 new episodes of TB and 60,000 deaths secondary to TB were reported in Latin America and the Caribbean [1] [2] [3] [4] .
Nosocomial transmission of M. tuberculosis has been well documented in the United States and Europe [5] [6] [7] [8] .
In these outbreaks, a patient with TB was the source, and patient-to-health care worker (HCW), patient-topatient, and HCW-to-patient transmissions have been documented. In most outbreaks, affected HCWs have been those directly involved in patient care (e.g., HCWs in emergency departments [EDs] , inpatient medical wards, and inpatient HIV wards). Less commonly, M. tuberculosis transmission to HCWs during autopsies [9] , wound irrigation, bronchoscopy [10, 11] , and in the intensive care setting [12] has been documented. None of the published outbreaks has involved laboratory personnel.
In developing countries, nosocomial transmission may pose a serious threat to HCWs, because there are more patients with infectious TB, open wards, and minimal or absent TB infection control precautions [13] [14] [15] [16] . Although documenting nosocomial transmission in high-prevalence areas is difficult because of the background widespread community transmission, a small number of studies in developing countries in Africa, Asia, and Latin America suggest that there is a high risk of acquiring TB infection among HCWs in health care settings [15, [17] [18] [19] [20] . Most of these studies have documented tuberculin skin test (TST) conversion among HCWs, with active TB developing in a few, and have identified contact with TB patients and duration of employment as the main risk factors for occupational TB infection in HCWs. It has been suggested that absence of TB infection control measures, which, when fully implemented, have proven effective [21] , is a major contributor to M. tuberculosis transmission [15, 17] . These studies emphasize the threat of nosocomially acquired M. tuberculosis infection and the urgent need for a preventive intervention in public health. To date, no M. tuberculosis outbreak in laboratory workers has been reported in the English-language literature.
Peru has one of the highest TB rates in Latin America, with ∼27,000 new patients reported in 1998 (rate, 111 cases per 100,000 patients) [2, 4] . The Instituto Peruano de la Seguridad Social (IPSS), 1 of the 2 governmental health care systems, serves ∼7 million people, or one-third of the Peruvian population. In the late 1980s, IPSS implemented a TB control program based on the recommendations of the Peruvian National Tuberculosis Program. Since 1993, the International Union against Tuberculosis and Lung Disease (IUATLD) has documented consistent improvement in the implementation of the IPSS TB program and in treatment outcomes [22, 23; N. E. Billo and J. A. Caminero-Luna, unpublished data]. Rates for all forms of active TB in the population covered by the IPSS have steadily decreased, from 140 TB patients per 100,000 persons in 1993 to 90 per 100,000 in 1995; however, rates of TB among HCWs are unknown both within the IPSS and on a national level.
The Hospital Nacional Guillermo Almenara Irigoyen (HNGAI), a 900-bed IPSS referral hospital, provides a comprehensive range of pediatric, medical, and surgical inpatient and outpatient services. In December 1996, pulmonary TB was diagnosed in 6 HCWs from the central laboratory of HNGAI. In May 1997, HNGAI's occupational health department began a hospital-wide TB screening program. Of 2300 HCWs, 1600 were screened and 44 were identified who had presumptive active pulmonary and/or pleural TB; 20 (45%) of those 44 were from the central laboratory. Because of these findings, the Centers for Disease Control and Prevention and the IUATLD were invited to assist in the investigation. Herein, we report the results of our investigation.
METHODS
Case definition and ascertainment. A "case HCW" was defined as any HNGAI HCW in whom pulmonary TB was diagnosed from January 1994 through January 1998 (the study period). To increase the specificity of our case definition, we required (1) laboratory documentation of a positive acid-fast bacillus (AFB) smear or M. tuberculosis culture of sputum, bronchoalveolar lavage fluid, or lung tissue and (2) medical record documentation of a diagnosis and therapy for TB. Potential case HCWs were identified by cross-matching HNGAI's HCW database with the ED, inpatient, outpatient clinic, hospital discharge diagnosis, mycobacteriology laboratory, pharmacy, occupational health, and TB program electronic databases. Case HCWs were subsequently confirmed by a review of medical and laboratory records of potential case HCWs. Demographic, clinical, and laboratory data were obtained from medical and laboratory records.
Determination of existence of an outbreak. Rates of active pulmonary TB among HCWs were calculated and compared for the entire hospital and for each hospital area for the study period and by year. Denominators were calculated using HNGAI's personnel database. Potential systematic laboratory cross-contamination was assessed by examining dates of positive sputum smear and culture processing.
HCW TST survey. To determine risk factors for and the extent of M. tuberculosis HCW infection, we administered a questionnaire and a 1-step TST to HCWs working in medicine wards, the ED, the intensive care unit (ICU), or the laboratory. Eligible HCWs were those with no history of prior active TB and either negative or unknown results of a prior TST or no prior TST. Examination for BCG vaccination scar was not possible logistically, so we collected only verbal information. A team of 8 HCWs was trained to administer and read TSTs (2 tuberculin units of 1 mL of PPD RT23 [Sweden] , by use of the standard Mantoux method [24] ). The questionnaire was administered at the time of the TST. All TSTs were read by 4 of the 8 investigators at 48-72 h; a positive TST was defined as у10 mm of induration transverse to the long axis of the forearm.
Definitions. "Clinical areas" were medical wards, the ED, and the ICU. In our analysis, we combined the ED and the ICU, because they shared personnel, were located in the same wing, and both housed intubated patients. "Common staff areas" were defined as areas where HCWs interacted (e.g., coffeebreak areas, hospital cafeterias, and general dressing rooms). Finally, we defined "direct patient caregivers" as physicians, nurses, and nurse-assistants.
Analysis of risk factors for TB infection or disease. Data were collected on standardized forms and analyzed using Epi Info version 6.03 (Centers for Disease Control and Prevention) and SAS PC (SAS Institute). We calculated the prevalence of TB infection, using the total number of TST-positive HCWs as the numerator and the number of HCWs included in the TST survey as the denominator. We performed 2 separate analyses: 1 for the laboratory (where there was minimal patient contact) and 1 for the combined clinical areas. To assess risk factors for TB infection, we compared TB infection prevalence rates for different factors. Categorical variables were compared using either the x 2 test or Fisher's exact test. Odds ratios and 95% confidence intervals were calculated using standard methods. Continuous variables were compared using either Student's t test or the Kruskal-Wallis test. P values were 2-tailed, and was considered significant. We used multiple logistic P ! .05 regression modeling to assess the independence of potentially predictive factors. Variables that were found to be significant in univariate analyses or for which were included in the P ! .2 pool of predictors. Finally, because an increase in the number of TB patient admissions could have contributed to the high TB rates among HCWs, we examined the distribution of TB patient admissions by year in those areas with higher rates of HCW pulmonary TB.
Assessment of TB infection control practices. We reviewed infection control protocols in areas that were accessible to potentially infectious TB patients (e.g., medicine wards, ED, ICU, cafeteria, laboratory, bronchoscopy suites, procedure rooms) and interviewed HCWs regarding infection control practices. We examined patient room and laboratory airflow direction by smoke-tube testing. Although the original mycobacteriology laboratory had been closed in response to the outbreak, we visited this area and inspected its biosafety cabinet (BSC). In addition, we interviewed and observed laboratory personnel to determine specimen-handling procedures [25] . Finally, we inspected the provisional mycobacteriology laboratory where specimens were prepared for shipping to the outside reference laboratory.
RESULTS
Case ascertainment and characteristics. We identified 36 case HCWs. The median age was 35 years (range, 20-46 years), and 18 (50%) of the 36 were female (table 1). The most common job category was "physician," followed by "laboratory technician," "nurse," and "licensed practical nurse." The largest number of case HCWs worked in the central laboratory, followed by the medicine wards and the ED/ICU areas. One case HCW was pregnant, and another had diabetes mellitus. Six case HCWs (17%) had a history of TB, but no laboratory confirmation or documentation of therapy of the previous episode could be found in their medical records. Of the 6, 2 stated they had TB disease before the study period but did not remember details of their treatment. Therefore, during the study period, they may have had reactivation of previously incompletely treated TB disease. The other 4 were possibly infected during the study period. Two were diagnosed before 1994, treated, and considered "cured"; these HCWs may have been reinfected or may have relapsed. The other 2 HCWs were diagnosed after 1 January 1994 but did not complete therapy. These HCWs most likely had relapses but could have been reinfected. Of the 36 case HCWs, 29 (80%) were AFB sputum smear positive; 18 of the 29 had positive results of culture as well as of sputum smear, and 7 had positive results of culture alone. For the case HCWs for whom data were available on duration of symptoms, duration of cough before diagnosis ranged from 1 to 558 days (median, 22 days). The interval from diagnosis to initiation of therapy ranged from 0 to 170 days (median, 0 days). Only 1 case HCW had multidrug-resistant tuberculosis. Most case HCWs did not receive the standard therapy recommended by the Peruvian National Tuberculosis Program (table 1) . M. tuberculosis isolates from HCWs and other patients had been discarded and were unavailable for genotyping.
Determination of existence of an outbreak. Although diagnoses were made in case HCWs during the entire study period, 22 (61%) received a diagnosis of TB from November 1996 through January 1998 (figure 1), including 12 (80%) of the case HCWs employed in laboratory areas. In contrast, there was no temporal clustering of case HCWs employed in the rest of the hospital, even during the periods when active screening was undertaken. No clustering of case HCWs by dates of positive smear or culture results, which would suggest laboratory contamination, was observed. Next, we calculated rates of active pulmonary TB among HCWs by year and hospital work area. For the entire hospital, the TB rate was stable in 1994 and 1995 and then increased during the following 2 years (figure 2). In 1997, the rate was significantly higher than the average rate for the previous 3 years (792 vs. 222 per 100,000 HCWs; RR, 3.5; 95% CI, 1.8-6.9;
). When we compared rates of TB in P ! .001 1997 among HCWs by hospital work area, the rate among HCWs employed in laboratory areas was higher than the rate for HCWs employed in all other areas (table 2) and also was significantly higher than the rate in the medicine wards, which had the second highest HCW TB rate (6977 vs. 932 per 100,000 HCWs; RR, 7.5; 95% CI, 2.4-22.9;
). When we com-P ! .001 pared the trends in HCW TB rates within areas during the study period, only the laboratory rate in 1997 was significantly higher than the average rate of the preceding years (6977 vs. 581 per 100,000 HCWs; RR, 12.0; 95% CI, 2.4-22.9;
). P ! .001
The central laboratory included the following sections: microbiology, pathology, hematology, biochemistry, and blood bank. In 1997, the rate of HCW TB was not significantly higher among HCWs employed in the microbiology section than among those in other laboratory areas. One of the 2 HCWs working in the mycobacteriology laboratory was a case HCW. However, we could not demonstrate an increased TB rate in this area on the basis of so small a sample. Interestingly, no case HCW was identified in the blood bank, which had its own entrance and could not be entered directly from the other laboratory areas. HCW TST survey. Of 704 HCWs targeted for inclusion in the survey, 516 (73%) were enrolled, and 188 (27%) were not found or refused to participate. Of those enrolled, 270 (52%) underwent a TST; 129 (25%) were not eligible for a TST because they had a history of TB, were case HCWs, or had positive results on a previous TST; and 117 (23%) refused to undergo a TST or did not return for the reading. Of the 270 HCWs who underwent TSTs, 170 (63%) had a reaction у10 mm in diameter, and 125 (46%) had reactions у15 mm in diameter.
Assessment of risk factors for TB infection or disease. Of the 192
HCWs tested who worked in the clinical wards, 118 (61%) were TST positive; of the 78 HCWs tested who worked in the laboratory, 52 (67%) were TST positive. In the clinical wards, TST-positive HCWs were older than TST-negative HCWs and had been working in the hospital longer. In addition, TST-positive HCWs were more likely to have been working in the hospital for at least 1 year, to have worked in the medicine wards rather than the ED/ICU areas, to have had contact with a person with active TB, and to have helped patients collect sputum samples (tables 3 and 4). In the laboratory, TST-positive HCWs also were older, had been working in the hospital longer, and were more likely to have had contact with a person with active TB. In addition, they were more likely to routinely use common staff areas than were TST-negative HCWs (tables 3 and 4). In both analyses, factors not significantly associated with an increased risk for TB infection included sex; BCG vaccination; working in rotating shifts; working overtime; drawing blood; washing, feeding, or moving patients; or working in the spirometry, HIV, or bronchoscopy areas.
In multivariate analyses, among clinical HCWs, contact with a person with active TB, helping patients collect sputum, and time worked in the hospital were independently associated with an increased risk of M. tuberculosis infection. Among laboratory HCWs, only the use of common staff areas remained significantly associated with increased risk for M. tuberculosis infection (table 5) . Other factors included in the pool of variables for both models were BCG vaccination, sex, age, and exposure to either dressing or coffee-break rooms.
Last, we examined the distribution of TB patient admissions as a risk factor for HCW TB. During the study period, 400-500 TB patients were admitted annually to the medicine wards or the ED/ICU areas. Although the total number of TB admissions decreased during the study period, this change did not reach statistical significance.
Assessment of TB infection control practices. There was no written TB infection control policy, and few TB infection control measures were in place in the hospital (e.g., expediting identification, diagnosis, and initiation of therapy for potentially infectious TB patients). Protocols for cohorting or isolating potentially infectious patients also were not in place, and rooms were designed for 4-8 patients. High-risk areas (e.g., bronchoscopy suites, autopsy areas, and surgical theaters) did not have engineering controls. Adequate respiratory protection (e.g., N95 respirator) was not in use (HCWs wore regular surgical masks while examining infectious TB patients or performing bronchoscopies, autopsies, or surgery).
Assessment of the laboratory. The laboratory was a 2-story building with no ventilation system. There were multiple interactions between HCWs from the different laboratory sections, especially in the general dressing and coffee-break rooms, which were located within each section, were very small (2 ϫ 3 m and 2 ϫ 2 m, respectively), and at break time were crowded. In addition, all HCWs but those assigned to the mycobacteriology laboratory and the blood bank would rotate periodically between sections. The blood bank was adjacent to the other sections in the laboratory, but to access those sections, HCWs had to exit at the far end of the blood bank and walk around the entire laboratory to the main entrance of the building. Therefore, members of the blood bank staff were relatively isolated from other laboratory HCWs and did not share common areas with them. The old mycobacteriology laboratory was a biosafety I facility that did not meet requirements for processing level III organisms, such as M. tuberculosis [12] . The BSC used was class II, which should provide protection to personnel, specimen, and the environment; however, the BSC had not received proper certification by field testing since its purchase in 1994. General laboratory safety guidelines and biohazard warning signs were prominently displayed, but there were no detailed standard operating procedures for working in the mycobacteriology laboratory. AFB smears were not performed immediately after they were obtained, and results were not reported directly to the clinicians. No obvious procedural flaws in M. tuberculosis processing were detected. All procedures were performed in the BSC. No specific area was assigned for sputum collection; outpatients generally produced sputum samples in public rest rooms located in the laboratory, which laboratory staff almost never used. No laboratory accidents had been reported, and there was no ventilation system connecting this area to the rest of the laboratory areas. The new provisional mycobacteriology laboratory also was a biosafety I facility that did not meet requirements for processing level III organisms. Because the operations of the mycobacteriology laboratory had been severely curtailed 6 months before our investigation, however, the laboratory was used only as a specimen collection center.
DISCUSSION
In our investigation, we documented a high rate of M. tuberculosis infection and a high rate of active pulmonary TB among HCWs at HNGAI. During 1997, the rate among HCWs was 4-8 times higher than that reported for the country [2] . Of 36 case HCWs, only 2 had TB before the study period. Although they received therapy and were considered "cured," their active disease could reflect either reactivation of the previous infection or reinfection. Also, we found neither clustering of HCW TB by dates of diagnosis nor other evidence of laboratory contamination, and demographic characteristics of case HCWs and TST-positive HCWs were similar. Moreover, only 2 case HCWs had other health conditions (pregnancy or diabetes) that might have placed them at increased risk of TB. Unfortunately, no M. tuberculosis isolates were saved, so neither potential virulence factors of the strain nor species relatedness could be assessed.
Our TST survey showed that 170 (63%) of the 270 HCWs tested had positive reactions. The rate of positive TSTs or TB disease would have been even higher (299 [75%] of 399 HCWs) had the 129 HCWs with prior positive TST results or TB disease been included. This proportion is markedly higher than the levels found in previous community-based prevalence studies in Peru, which have shown that ∼35% of the population tested was TST positive [26, 27] .
At HNGAI, HCW risk of active pulmonary TB varied by hospital work area. HCWs employed in the medicine wards or the ED/ICU areas had consistently higher rates of active pulmonary TB than did HCWs in the rest of the hospital, with the exception of those employed in the laboratory areas. Identified risk factors for M. tuberculosis infection in these clinical areas were similar to risk factors reported in other studies (conducted in Thailand, Brazil, and the Ivory Coast), including longer duration of employment, having direct patient contact, or having contact with a person with active TB [15, 17, 19, 20] . In addition, we found that HCWs working in the medicine wards were more likely to be infected with M. tuberculosis than were HCWs employed in the ED/ICU. This may reflect the higher rates of active pulmonary TB found among HCWs working in the medicine wards and also may be influenced by the increased volume and length of stay of TB patients in these wards. Finally, the stability in the trend of active TB rates found among HCWs employed in medicine wards and in the ED/ICU is consistent with our findings of high rates of TB patient admissions to these areas. All these findings and the lack of TB infection control measures suggest high endemic levels of M. tuberculosis transmission to HCWs in these clinical areas. Patient-to-HCW transmission is also suggested, because most of the risk factors for TB infection were related to the duration and extent of patient contact.
In the laboratory, not only did HCWs have consistently higher rates of active TB during most of the study period, but a significant increase in those rates was seen in 1997, which suggests both a high endemic rate and an outbreak in the laboratory. It is unlikely that these findings reflect bias resulting from the hospital's active surveillance efforts, because nearly 80% of all HCWs were screened for active disease (including chest radiography, TST, and sputum smear of those with respiratory symptoms), during late 1996 and early 1997, including HCWs employed in areas such as surgery, pediatrics, and hospital areas where no increase in HCW TB was detected.
The only risk factor for TB infection identified in laboratory HCWs was the use of common staff areas. None of these areas was ventilated. The common dressing and coffee-break rooms in each section were very small and at break time would be very crowded. In light of the prolonged period for which HCWs were working (and going to these areas) while symptomatic, the potential for HCW-to-HCW M. tuberculosis transmission in these 2 areas would be high. This finding also is consistent with the absence of case HCWs in the blood bank. The blood bank HCWs were relatively isolated from the rest of the laboratory, did not visit the common staff areas, and did not participate in the rotation schedule among services. These factors separated them from symptomatic laboratory HCWs and may have protected them from acquiring M. tuberculosis infection. The mycobacteriology laboratory section was an unlikely source of TB. No accidents had been reported, there was no ventilation from this area to the rest of the laboratory areas, and there was no rotation of personnel from other laboratory sections to the TB section. Our findings that case HCWs had long symptomatic periods during which they did not seek therapy and that use of common staff areas was the major risk factor for TB infection suggest that HCW-to-HCW is the most likely mechanism of transmission in this outbreak.
For case HCWs in all areas of the hospital, we confirmed long coughing periods, delays in diagnosis, and-more worrisome-delays in starting therapy after laboratory confirmation of active TB. In Peru, the stigma associated with a TB diagnosis may be a barrier to early diagnosis and therapy. In addition, HNGAI regulations requiring that HCWs with a TB diagnosis take medical leave at a reduced pay for the entire duration of therapy may have served as a disincentive for HCWs to seek early evaluation of symptoms compatible with TB. All of these factors would facilitate longer duration of infectivity and enhanced HCW-to-HCW M. tuberculosis transmission in the entire hospital.
There are at least 2 major limitations in our investigation. First, M. tuberculosis isolates were not available for genotyping to assess their relatedness. Second, there is the potential for selection bias, because 310 (44%) of the original population targeted for the TST survey were not available or refused participation in the survey, although we systematically tried to recruit from all hospital work areas.
TB is an increasing public health threat, especially in developing countries, where resources are limited and there are numerous infectious TB patients. Nosocomial transmission of M. tuberculosis is of particular concern to HCWs. In hospitals, implementation of well-organized TB surveillance and infection control programs is mandatory. Even in the absence of costly engineering controls, these programs should emphasize the importance of administrative controls to ensure early identification and isolation of potentially infectious TB patients, prompt evaluation of symptomatic HCWs, and compliance with World Health Organization infection control and directly observed therapy recommendations [4] .
